Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 60

Sort by

Sort Order Select

Journal Articles

Innovative Treatment for Post-COVID Syndrome: A Clinical Breakthrough

Ying Chieh Chen, Joseph Rosenthal, Gili Su, Ernest Lau, Chinhhsin Chen, Aristides Canalejo Martinez, Jonas Wang, Tong Young Lee

Blood (2024) 144 (Supplement 1): 7233.

https://doi.org/10.1182/blood-2024-210709

Published: 2024

Journal Articles

Risk of Hematologic Malignancies in Patients with Acute Myocardial Infarction: A Nationwide Population-Based Cohort Study

Seug Yun Yoon, Sun Young Jeong, Seong Soon Kwon, Mina Kim, Min-Young Lee, Kyoung Ha Kim, Namsu Lee, Jong-Ho Won

Blood (2024) 144 (Supplement 1): 2315.

https://doi.org/10.1182/blood-2024-193311

Published: 2024

Journal Articles

Human IFN-α2- and PD-L1-Modified T Cells (αp-T cells) Inhibit Graft-Versus-Host Disease but Retain Anti-Leukemia Activity

Yuanyuan Tian, Bei Jia, Che Young Lee, Qingrong Huang, Chenchen Zhao, Ciril Abraham, Wenbin Mo, Mimi Chen, Ying WANG, Hong Zheng, Yi Zhang

Blood (2024) 144 (Supplement 1): 87.

https://doi.org/10.1182/blood-2024-203954

Published: 2024

Journal Articles

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD

Ying Wang, Shan He, Gennaro Calendo, Tien Bui, Yuanyuan Tian, Che Young Lee, Yan Zhou, Xin Zhao, Ciril Abraham, Wenbin Mo, Mimi Chen, Ruqayyah Sanders-Braggs, Jozef Madzo, Jean-Pierre Issa, Elizabeth O. Hexner, David L. Wiest, Ran Reshef, Hai-Hui Xue, Yi Zhang

Blood (2024) 143 (2): 166–177.

https://doi.org/10.1182/blood.2023021126

Published: 2024

Includes: Supplemental data

Journal Articles

Identifying Inflammatory Pathways That Promote RBC Alloimmunization in Patients with Sickle Cell Disease

Rosario Hernandez-Armengol, June Young Lee, Kausik Paul, Che-Yu Chang, Tomohiro Shibata, David R Gibb

Blood (2023) 142 (Supplement 1): 2663.

https://doi.org/10.1182/blood-2023-190681

Published: 2023

Journal Articles

Modakafusp Alfa Demonstrates Type I Interferon-Mediated Innate and Adaptive Immune Enhancement in a Phase 1/2 Study in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Gurpanna Saggu, Min Young Lee, Faith Dunbar, Reshma Singh, Kris Sachsenmeier, Dan T. Vogl, Shebli Atrash, Sarah A. Holstein, Omar Nadeem, Jonathan L. Kaufman, Adarsh Joshi, Kaveri Suryanarayan, Sabrina Collins

Blood (2023) 142 (Supplement 1): 3316.

https://doi.org/10.1182/blood-2023-177909

Published: 2023

Journal Articles

Chip-Based Digital PCR Platform, Lab on an Array, the Newly Developed Highly Accurate and Sensitive Method for the Detection of BCR-ABL1 Transcripts in Chronic Myeloid Leukemia

Hyun-Woo Song, Kyung-Mi Ki, Soo Hyun Kim, Sung-Hyun Kim, Min-Sik Song, Do Young Lee, Seung-Shick Shin, Dong-Wook Kim

Blood (2022) 140 (Supplement 1): 3904–3905.

https://doi.org/10.1182/blood-2022-168020

Published: 2022

Journal Articles

Neutrophil-to-Lymphocyte Ratio Is More Accurate Than Erythropoietin Level for the Polycythemia Vera Diagnosis

Min Jung Kim, Min-Young Lee, Kyoung Ha Kim, Namsu Lee, Jong Ho Won, Seug Yun Yoon

Blood (2022) 140 (Supplement 1): 6868–6869.

https://doi.org/10.1182/blood-2022-165689

Published: 2022

Journal Articles

The Effects of Iron Deficiency on the Gut Microbiota in Young Women

Seug Yun Yoon, Min Jung Kim, Min Young Lee, Kyoung Ha Kim, Namsu Lee, Jong Ho Won

Blood (2022) 140 (Supplement 1): 5348–5349.

https://doi.org/10.1182/blood-2022-162217

Published: 2022

Journal Articles

Review of End-of-Life Care and Supportive Care during Disease Course in Elderly Patients with Multiple Myeloma

Sunyoung Jeong, Seug Yun Yoon, Min Young Lee, Kyoung Ha Kim, Nam Su Lee, Jong Ho Won

Blood (2021) 138 (Supplement 1): 4731.

https://doi.org/10.1182/blood-2021-150237

Published: 2021

Journal Articles

A Study on Preclinical Efficacy, Underlying Mechanisms, and Sensitivity Markers of a Novel Hypomethylating Agent Ntx-301 in Acute Myeloid Leukemia

Byungho Lim, Dabin Yoo, Kyung-jin Cho, Daeun Choi, Myoung Eun Jung, Doo Young Jung, Jin Soo Lee, Younghwa Chun, Areum Go, Ha Young Lee, Gildon Choi

Blood (2021) 138 (Supplement 1): 2348.

https://doi.org/10.1182/blood-2021-152304

Published: 2021

Journal Articles

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study

Seok Jin Kim, Jing Quan Lim, Yurike Laurensia, Junhun Cho, Sang Eun Yoon, Ji Young Lee, Kyung Ju Ryu, Young Hyeh Ko, Youngil Koh, Duck Cho, Soon Thye Lim, Marie Beck Enemark, Francesco D’Amore, Mette Bjerre, Choon Kiat Ong, Won Seog Kim

Blood (2020) 136 (24): 2754–2763.

https://doi.org/10.1182/blood.2020007247

Published: 2020

Includes: Supplemental data

Journal Articles

Type I Interferon Gene Signature in Peripheral Blood Mononuclear Cells of Sickle Cell Disease Patients and a Connection to RBC Alloimmunization

Emaan Madany, BS, June Young Lee, B.S., Jeanne E. Hendrickson, MD, David R Gibb, MDPhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142935

Published: 2020

Journal Articles

HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway

Jung Kwon Lee, SungMyung Kang, Xidi Wang, Jesusa L. Rosales, Xu Gao, Hee-Guk Byun, Yan Jin, Songbin Fu, Jinghua Wang, Ki-Young Lee

Blood (2019) 133 (20): 2222–2232.

https://doi.org/10.1182/blood-2018-12-890236

Published: 2019

Includes: Supplemental data

Journal Articles

Randomized Phase II Trial of Combination Idiotype Vaccine and Adoptive Cell Transfer of Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Blood (2017) 130 (Supplement 1): 3193.

https://doi.org/10.1182/blood.V130.Suppl_1.3193.3193

Published: 2017

Journal Articles

Expression Levels of PD-1 on CD8+ T Cells in Chronic Myeloid Leukemia with and without BCR-ABL1 kinase Mutation

Min Young Lee, MD PhD, Chan-jeoung Park, MD, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, MD, Chang Ahn Seol, Eul-Ju Seo, MD, Jung-Hee Lee, MD PhD

Blood (2017) 130 (Supplement 1): 4178.

https://doi.org/10.1182/blood.V130.Suppl_1.4178.4178

Published: 2017

Journal Articles

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

Min Young Lee, MD PhD, Chan-jeoung Park, MD, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, MD, Jung-Hee Lee, MD PhD, Jung Yong Hong, Dok Hyun Yoon, MD PhD, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 4400.

https://doi.org/10.1182/blood.V130.Suppl_1.4400.4400

Published: 2017

Journal Articles

Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)

Bertrand Coiffier, Juan-Manuel Sancho, Wojciech Jurczak, Jin Seok Kim, Raj V Nagarkar, Edvard Zhavrid, Jose Angel Hernandez Rivas, Aliaksandr Prokharau, Mamia Zodelava, Dzhelil Osmanov, Michinori Ogura, Christian Buske, Larry Kwak, Sang Joon Lee, Sung Young Lee, Yun Ju Bae, Won Seog Kim

Blood (2016) 128 (22): 1807.

https://doi.org/10.1182/blood.V128.22.1807.1807

Published: 2016

Journal Articles

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

Blood (2016) 127 (8): 1017–1023.

https://doi.org/10.1182/blood-2015-10-676098

Published: 2016

Includes: Supplemental data

Journal Articles

Outcome of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Various Frontline Second-Generation Tyrosine Kinase Inhibitors: A Single-Center Experience

Sung-Eun Lee, Soo Young Choi, Soo-Hyun Kim, Hye-Young Song, Hea-Lyun Yoo, Mi-Young Lee, Ki-Hoon Kang, Hee-Jeong Hwang, Eun-Jung Jang, Dong-Wook Kim

Blood (2015) 126 (23): 1595.

https://doi.org/10.1182/blood.V126.23.1595.1595

Published: 2015

NARROW

Innovative Treatment for Post-COVID Syndrome: A Clinical Breakthrough

Risk of Hematologic Malignancies in Patients with Acute Myocardial Infarction: A Nationwide Population-Based Cohort Study

Human IFN-α2- and PD-L1-Modified T Cells (αp-T cells) Inhibit Graft-Versus-Host Disease but Retain Anti-Leukemia Activity

Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1–mediated immune suppression during GVHD

Identifying Inflammatory Pathways That Promote RBC Alloimmunization in Patients with Sickle Cell Disease

Modakafusp Alfa Demonstrates Type I Interferon-Mediated Innate and Adaptive Immune Enhancement in a Phase 1/2 Study in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

Chip-Based Digital PCR Platform, Lab on an Array, the Newly Developed Highly Accurate and Sensitive Method for the Detection of BCR-ABL1 Transcripts in Chronic Myeloid Leukemia

Neutrophil-to-Lymphocyte Ratio Is More Accurate Than Erythropoietin Level for the Polycythemia Vera Diagnosis

The Effects of Iron Deficiency on the Gut Microbiota in Young Women

Review of End-of-Life Care and Supportive Care during Disease Course in Elderly Patients with Multiple Myeloma

A Study on Preclinical Efficacy, Underlying Mechanisms, and Sensitivity Markers of a Novel Hypomethylating Agent Ntx-301 in Acute Myeloid Leukemia

Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study

Type I Interferon Gene Signature in Peripheral Blood Mononuclear Cells of Sickle Cell Disease Patients and a Connection to RBC Alloimmunization

HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway

Randomized Phase II Trial of Combination Idiotype Vaccine and Adoptive Cell Transfer of Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation

Expression Levels of PD-1 on CD8+ T Cells in Chronic Myeloid Leukemia with and without BCR-ABL1 kinase Mutation

Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma

Pharmacokinetic and Safety of CT-P10, a Biosimilar Candidate to the Rituximab Reference Product, in Patients with Newly Diagnosed Advanced Stage Follicular Lymphoma (AFL)

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies

Outcome of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients Treated with Various Frontline Second-Generation Tyrosine Kinase Inhibitors: A Single-Center Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only